Rebecca Wolitz, B.A., J.D., PhD
Education
- PhD, Yale University
- JD, Yale Law School
- MPhil, Yale University
- MA, Yale University
- BA, Rutgers University-New Brunswick
Biography
Rebecca Wolitz is an Assistant Professor of Law at the Moritz College of Law. Prior to joining Moritz, Professor Wolitz was a research fellow with the Program on Regulation, Therapeutics, and Law at Harvard and a fellow with Stanford Law School’s Center for Law and the Biosciences. Professor Wolitz holds a JD and PhD from Yale. Her scholarship focuses on various legal and ethical issues at the intersection of health, intellectual property, and corporate law. Her articles have appeared in the Northwestern University Law Review, the Indiana Law Journal, the Seton Hall Law Review, the Journal of Legal Medicine, Bioethics, the Lancet, and the American Journal of Public Health.
What We Are Owed, 58 Conn. L. Rev. 385 (forthcoming 2026)
Shareholder Resolutions and Access to Medications, in Health Law as Private Law (Susannah Baruch, I. Glenn Cohen, Wendy Epstein, Carmel Shachar & Christopher Robertson eds., 2025).
Government Patent Use to Promote Public Health in the United States: Overcoming Non-Patent Exclusivities, 112 Am. J. Pub. Health 1110 (2022)
Links: SSRN
States, Preemption, and Patented Drug Pricing, 52 Seton Hall L. Rev. 385 (2021)
Links: SSRN
Legal Strategies for Reining in “Unconscionable” Prices for Prescription Drugs, 114 Nw. U. L. Rev. 859 (2020)
Links: SSRN
The Pay-Twice Critique, Government Funding, and Reasonable Pricing Clauses, 39 J. Legal Med. 177 (2019)
Links: SSRN
A Corporate Duty to Rescue: Biopharmaceutical Companies and Access to Medications, 94 Ind. L.J. 1163 (2019)
Links: SSRN
Refocusing the Responsiveness Requirement, 27 Bioethics 151 (2013)
The Use of Experimental Therapies: Awakenings, in The Picture of Health: Medical Ethics and the Movies (Henri Colt et al. eds., 2011).
Rethinking the Responsiveness Requirement for International Research, 374 Lancet 847 (2009)